Globus Medical, Inc.
NYQ: GMEDLive Quote
📈 ZcoreAI Score
Our AI model analyzes Globus Medical, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get GMED Z-Score →About Globus Medical, Inc.
Healthcare
Medical Devices
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
📊 Fundamental Analysis
Globus Medical, Inc. demonstrates exceptional profitability, with a profit margin of 18.3%.
The company recently reported 25.7% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 12.3%, which suggests room for improvement in capital utilization.
At a current price of $90.42, GMED currently sits at the 78th percentile of its 52-week range (Range: $51.79 - $101.40).
💰 Valuation Insight
GMED is valued broadly in line with the sector at a PE of 23.07. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
✅
Profit Margin
Excellent
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$12.23B
Trailing P/E
23.07
Forward P/E
18.24
Beta (5Y)
1.09
52W High
$101.40
52W Low
$51.79
Avg Volume
1.13M
Day High
Day Low